Literature DB >> 24926571

Ulinastatin attenuates renal interstitial inflammation and inhibits fibrosis progression in rats under unilateral ureteral obstruction.

Guo-Tao Jiang1, Xiao Chen1, Dong Li1, Hui-Xia An1, Jun-Dong Jiao1.   

Abstract

The aim of the present study was to examine the protective effects of the urinary trypsin inhibitor ulinastatin (UTI) on renal interstitial inflammation and fibrosis in rats subjected to unilateral ureteral obstruction (UUO). A total of 24 male Wistar rats were randomly divided into the three groups; the sham operation (SOR) group (n=8), the UUO group (n=8) and the UUO+UTI group (post‑UUO UTI treatment, n=8). UUO was performed with complete ligation of the left ureter. As a medical intervention, saline (4 ml kg‑1 d‑1) and UTI (40000 units kg‑1 d‑1) were injected, respectively, into the animals of the corresponding groups on day one following surgery. The rats in all three groups were euthanized on day seven post surgery. Blood samples were harvested for blood urea nitrogen (BUN) and serum creatinine (Scr) content measurements. The degree of interstitial pathological changes in the tissues from the obstructed kidneys were observed through hematoxylin and eosin (H&E) and Masson staining. The CD68+ macrophage amount, tumor necrosis factor‑α (TNF‑α), interleukin 1β (IL‑1β), nuclear factor‑κB (NF‑κB), transforming growth factor‑β1 (TGF‑β1) and type I collagen (Col‑I) levels were examined immunohistochemically. The protein expression levels of NF‑κB were examined using western blot analysis. Total superoxide dismutase (SOD) activity and malondialdehyde (MDA) content of homogenates were measured spectrophotometrically. The results revealed that ulinastatin had no statistically significant effect on the BUN and Scr levels (P>0.05). However, in comparison with the SOR group, the UUO group exhibited significantly more severe renal interstitial pathological injury in terms of tubular dilation, epithelial atrophy, renal interstitial inflammatory cell infiltration and proliferation of fibrous tissues, as well as significantly elevated levels of interstitial CD68+ macrophages, IL‑1β, TNF‑α, NF‑κB, TGF‑β1 and Col‑I (P<0.01). UTI treatment significantly reduced UUO‑induced renal interstitial damage with reduced levels of interstitial CD68+ macrophages, IL‑1β, TNF‑α, NF‑κB, TGF‑β1 and Col‑I and MDA (P<0.05), and increased SOD levels (P<0.05). In conclusion, the present study indicated that UTI is able to effectively inhibit UUO‑side renal interstitial inflammatory reaction and fibrosis in UUO‑inflicted rats.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24926571     DOI: 10.3892/mmr.2014.2323

Source DB:  PubMed          Journal:  Mol Med Rep        ISSN: 1791-2997            Impact factor:   2.952


  6 in total

1.  The contribution of the immune system to genitourinary fibrosis.

Authors:  Karen M Doersch; Daniel Barnett; Abbie Chase; Daniel Johnston; J Scott Gabrielsen
Journal:  Exp Biol Med (Maywood)       Date:  2022-05-07

2.  Disease-syndrome combination modeling: metabolomic strategy for the pathogenesis of chronic kidney disease.

Authors:  Shasha Li; Peng Xu; Ling Han; Wei Mao; Yiming Wang; Guoan Luo; Nizhi Yang
Journal:  Sci Rep       Date:  2017-08-18       Impact factor: 4.379

3.  Apamin inhibits renal fibrosis via suppressing TGF-β1 and STAT3 signaling in vivo and in vitro.

Authors:  Mi-Gyeong Gwon; Hyun-Jin An; Hyemin Gu; Young-Ah Kim; Sang Mi Han; Kwan-Kyu Park
Journal:  J Mol Med (Berl)       Date:  2021-05-24       Impact factor: 4.599

4.  Ulinastatin inhibits renal tubular epithelial apoptosis and interstitial fibrosis in rats with unilateral ureteral obstruction.

Authors:  Qing-Fang Zhang
Journal:  Mol Med Rep       Date:  2017-10-03       Impact factor: 2.952

5.  Over-expressed microRNA-181a reduces glomerular sclerosis and renal tubular epithelial injury in rats with chronic kidney disease via down-regulation of the TLR/NF-κB pathway by binding to CRY1.

Authors:  Lei Liu; Xin-Lu Pang; Wen-Jun Shang; Hong-Chang Xie; Jun-Xiang Wang; Gui-Wen Feng
Journal:  Mol Med       Date:  2018-09-18       Impact factor: 6.354

6.  Effect of Ulinastatin on Syndecan-2-Mediated Vascular Damage in IDH2-Deficient Endothelial Cells.

Authors:  Su-Jeong Choi; Harsha Nagar; Jun Wan Lee; Seonhee Kim; Ikjun Lee; Shuyu Piao; Byeong Hwa Jeon; Cuk-Seong Kim
Journal:  Biomedicines       Date:  2022-01-17
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.